Crohn’s disease

AVSOLA (infliximab-axxq) for injection

AVSOLA (infliximab-axxq) for injection

AVSOLA is a tumor necrosis factor (TNF) blocker indicated for Crohn’s Disease, Pediatric Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis in combination with methotrexate, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasi

CIMZIA (certolizumab pegol) for injection

Certolizumab pegol is a TNF blocker. CIMZIA is a recombinant, humanized antibody Fab’ fragment, with specificity for human tumor necrosis factor alpha (TNFα), conjugated to an approximately 40kDa polyethylene glycol (PEG2MAL40K).

ENTYVIO (vedolizumab) for injection

Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells. ENTYVIO is indicated in adults for the treatment of moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease